Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy for the Treatment of Oral Pyogenic Granuloma

Table 2

Details of comparison between diode laser and sclerotherapy.

	Laser group	STS group	Chi sq-	-value
Details of site of involvement
Gingiva	19(44.2%)	13 (43.3%)	2.833	0.844 NS
Tongue	8 (18.6%)	7 (23.3%)
Buccal mucosa	3 (7%)	2 (6.7%)
Upper lip	3 (7%)	3 (10%)
Lower lip	2 (4.7%)	2 (6.7%)
Lower labial mucosa	2 (4.7%)	1 (3.3%)
Upper labial mucosa	1 (2.3%)	1 (3.3%)
Palate	3 (7%)	0
Retrocommissural area	2 (4.7%)	1 (3.3%)
Total	43 (100%)	30 (100%)
Details of size of involvement
Less than 1.5 cm	22 (51.1%)	11 (36.6%)	1.825	0.401 NS
1.6-2.0 cm	18 (41.8%)	15 (50%)
More than 2.0 cm	3 (7.1%)	4 (13.4)
Total	43 (100%)	30 (100%)
Details of the number of session
1 session	35 (81.3%)	05 (16.6%)	29.89	<0.001
More than 1 session	08 (18.6%)	25 (83.4%)
Total	43 (100%)	30 (100%)
Details of the side effects
Bleeding	27 (62.8%) (minor bleeding)	17 (56.7%) (minor bleeding)	0.277	0.599 NS
Pain	33 (76.7%)	30 (100%)	8.084	0.004
Edema	04 (9.3%)	10 (13.3%)	6.584	0.010
Superficial ulceration	00	30 (100%)	73	<0.001
Ecchymosis/necrosis	00	02(6.7%)	2.947	0.086 NS
Infection	00	02 (6.7%)	2.947	0.086 NS
Scarring	05 (11.6%)	02 (6.7%)	7.694	0.006
Details of the VAS scale on the 3^rd day of treatment
7-10 VAS	00	22 (7.37%)	51.447	<0.001
4-6 VAS	15 (34.9%)	08 (26.7%)
1-3 VAS	23 (53.5%)	00
0 VAS/no pain	05 (11.6%)	00
Total	43 (100%)	30 (100%)
Response of treatment to individual groups
Complete response	43 (100%)	27 (90%)	4.484	0.034
Moderate response	00	00
No response	00	03
Total	43 (100%)	30 (100%)
Time required for complete resolution/healing
1 week	08 (18.6%)	00	27.378	<0.001
2 weeks	23 (53.5%)	04 (13.3%)
3 weeks	12 (27.9%)	21 (7.5)
More than 3 weeks	00	05 (16.7%)
Total	43 (100%)	30 (100%)
Details of the recurrences based on site
Recurrences	04 (9.3%)	00	2.322	0.067 NS
No recurrence	39 (90.7%)	30 (100%)
Total	43 (100%)	30 (100%)